α-Synuclein impairs macroautophagy: implications for Parkinson’s disease
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Parkinson’s disease (PD) is characterized pathologically by intraneuronal inclusions called Lewy bodies, largely comprised of α-synuclein. Multiplication of the α-synuclein gene locus increases α-synuclein expression and causes PD. Thus, overexpression of wild-type α-synuclein is toxic. In this study, we demonstrate that α-synuclein overexpression impairs macroautophagy in mammalian cells and in transgenic mice. Our data show that α-synuclein compromises autophagy via Rab1a inhibition and Rab1a overexpression rescues the autophagy defect caused by α-synuclein. Inhibition of autophagy by α-synuclein overexpression or Rab1a knockdown causes mislocalization of the autophagy protein, Atg9, and decreases omegasome formation. Rab1a, α-synuclein, and Atg9 all regulate formation of the omegasome, which marks autophagosome precursors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





![Figure 6. α-Synuclein and Rab1a affect the colocalization of Atg9 and LC3 vesicles. (A) Endogenous immunostaining of Atg9 and p230 in SKNSH cells with α-synuclein overexpression or Rab1a knockdown. Empty GFP vector (EGFP) was used as a control for cells expressing α-synuclein–GFP. Images shown are z-stack projections. The Atg9 panels show a clear dispersal of the perinuclear localization with α-synuclein overexpression or Rab1a knockdown. Golgi fragmentation can be seen in the p230 columns. α-Synuclein overexpression causes an increase in the disorganization of the Golgi structure, a phenotype which is amplified with Rab1a knockdown. (Magnifications of these images have been deposited in the JCB DataViewer.) (B) Quantification of Atg9 colocalization with p230 (Pearson’s coefficient; ***, P < 0.001; two-tailed Student’s t test; n = 10 from one representative experiment). (C) Immunostaining of endogenous Atg9 and LC3 in cells with α-synuclein overexpression or Rab1a knockdown. Empty GFP vector (GFP) was used as a control for cells expressing α-synuclein–GFP. Colocalization is highlighted in white on merged panel (image generated by ImageJ Colocalization plugin). Images are single confocal planes to more precisely determine colocalization. Arrows denote colocalization events. (Magnifications of these images have been deposited in the JCB DataViewer.) (D and E) Quantification of Atg9 colocalization with LC3 (Pearson’s [D] and Mander’s coefficient [E]). The Mander’s coefficient shown in the first bar graph in E more accurately predicts Atg9/LC3 colocalization when LC3 vesicle number is reduced by Rab1a knockdown or α-synuclein overexpression (*, P < 0.05; **, P < 0.01; ***, P < 0.001; two-tailed Student’s t test; n = 10). (B, D, and E) Error bars represent SEM. See related Fig. S3. Bars: (A) 20 µm; (C) 10 µm.](https://figures.cochat.ai/paper-figures/72d18dd1e8114fddb91346cb34772324/synuclein-impairs-macroautophagy-implications-for-parkinsons-disease-figure-6.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pathologically meaningful levels of SNCA/α‐synuclein affect the intracellular localization of ATG9 via RAB1A (RAB1A, member RAS oncogene family), thereby perturbing autophagy dynamics in the brain of transgenic mice overexpressing SNCA/α‐synuclein (Winslow et al, 2010).”
From Autophagy in major human diseases (2021) · cites this paper as Winslow et al, 2010
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Conversely, overexpression of wild-type synuclein impairs autophagic activity, implying a functional relationship between synuclein and autophagic degradation19.”
From Loss of autophagy in dopaminergic neurons causes Lewy pathology and motor dysfunction in aged mice (2018) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., & Yoshimori, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5720 · Cited by 6,605 · cited 2×
“Further lipidation of LC3-I creates the autophagosome-associated form, LC3-II, which is known to be a robust marker of autophagosomes (Kabeya et al., 2000).”
A guided tour into subcellular colocalization analysis in light microscopy
BOLTE, S., & CORDELIÈRES, F. P. (2006) · Journal of Microscopy · doi:10.1111/j.1365-2818.2006.01706.x · Cited by 5,324 · cited 1×
“Cells were imaged in z stacks, and images were analyzed by the JaCoP plugin (Bolte and Cordelières, 2006) in the ImageJ software.”
Cui, C., Cui, J., Jin, F., Cui, Y., Li, R., Jiang, X., Tian, Y., Wang, K., Jiang, P., & Gao, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479571 · Cited by 5,203
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082 · cited 2×
“In addition to the accumulation of aggregate-prone proteins, the cells will not be as effective in clearing dysfunctional mitochondria (Twig et al., 2008) and will have increased susceptibility to certain apoptotic insults (Ravikumar et al., 2006); these are all processes that have been implicated…”
The role of autophagy during the early neonatal starvation period
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., & Mizushima, N. (2004) · Nature · doi:10.1038/nature03029 · Cited by 2,865
Impairment of starvation-induced and constitutive autophagy in Atg7 -deficient mice
Komatsu, M., Waguri, S., Ueno, T., Iwata, J., Murata, S., Tanida, I., Ezaki, J., Mizushima, N., Ohsumi, Y., Uchiyama, Y., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200412022 · Cited by 2,331 · cited 2×
“Mice defective for macroautophagy die soon after birth, and neuronal knockouts of such genes cause neurodegeneration accompanied by inclusion formation (Kuma et al., 2004; Komatsu et al., 2005).”
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
Klionsky, D. J., Abeliovich, H., Agostinis, P., Agrawal, D. K., Aliev, G., Askew, D. S., Baba, M., Baehrecke, E. H., Bahr, B. A., Ballabio, A., et al. (2008) · Autophagy · doi:10.4161/auto.5338 · Cited by 2,230 · cited 2×
“In this sense, the percentage of cells with mutant huntingtin aggregation can serve as a sensitive indicator of autophagic substrate clearance (Klionsky et al., 2008).”
Self-citationA Drosophila model of Parkinson's disease
Feany, M. B., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,118 · cited 1×
“62 (Jackson et al., 1998) with flies expressing wild-type -synuclein (UAS--syn; Feany and Bender, 2000) and with flies expressing constitutively active Rab1 (y1 P{UASp-YFP.”
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 8×
“Vol. 190 No. 6 1023–1037 www.jcb.org/cgi/doi/10.1083/jcb.201003122 JCB 1023 Correspondence to David C. Rubinsztein: dcr1000@hermes.cam.ac.uk Abbreviations used in this paper: ANOVA, analysis of variance; CMA, chaperonemediated autophagy; HD, Huntington’s disease; PD, Parkinson’s disease; PI(3)P, phosphatidylinositol-3…”
InfluentialAxe, E. L., Walker, S. A., Manifava, M., Chandra, P., Roderick, H. L., Habermann, A., Griffiths, G., & Ktistakis, N. T. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200803137 · Cited by 1,885 · cited 2×
“Thus, cells expressing GFP-labeled DFCP1 allow for the visualization of early events in autophagosome formation (Axe et al., 2008).”
Cited by
Items 201–300 of 826
Rab1 in cell signaling, cancer and other diseases
Yang, X.-Z., Li, X., Zhang, Y.-J., Rodríguez‐Rodríguez, L., Xiang, M.-Q., Wang, H.-Y., & Zheng, X. F. S. (2016) · Oncogene · doi:10.1038/onc.2016.81 · Cited by 98
Thakur, P. S., & Nehru, B. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8769-7 · Cited by 88
“In addition, it is also known to cause loss of the mitochondrial membrane potential [11], inhibit autophagy [12], and disrupt the mitochondrial transport in axons by causing tubulin depolymerization [13].”
BackgroundBiology and trafficking of ATG9 and ATG16L1, two proteins that regulate autophagosome formation
Zavodszky, E., Vicinanza, M., & Rubinsztein, D. C. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.04.025 · Cited by 88
“unknown dispersed compartment even without starvation [39].”
BackgroundSelf-citationMonaco, A., & Fraldi, A. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00037 · Cited by 95
“Moreover, α-synuclein overexpression may compromise ALP by inhibiting autophagy initiation via Rab1a inhibition (Winslow et al., 2010).”
BackgroundWang, S.-F., Wu, M.-Y., Cai, C.-Z., Li, M., & Lu, J. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.10.069 · Cited by 100
Genetic mutations and functions of PINK1
Kawajiri, S., Saiki, S., Sato, S., & Hattori, N. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.06.001 · Cited by 101
Autophagy as a Cellular Stress Response Mechanism in the Nervous System
Peker, N., & Gözüaçık, D. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.01.017 · Cited by 87
LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease?
O’Hara, D. M., Pawar, G., Kalia, S. K., & Kalia, L. V. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00577 · Cited by 85
“Blocking expression of LAMP2a results in compensatory upregulation of macroautophagy, but α-synuclein accumulation has also been shown to negatively affect this process by blockage of autophagosome formation (Massey et al., 2006; Winslow et al., 2010).”
BackgroundLimelight on Alpha-Synuclein: Pathological and Mechanistic Implications in Neurodegeneration
Wales, P., Pinho, R., Lázaro, D. F., & Outeiro, T. F. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130216 · Cited by 86
Ubiquitination Increases Parkin Activity to Promote Autophagic α-Synuclein Clearance
Lonskaya, I., Desforges, N. M., Hebron, M. L., & Moussa, C. E.-H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083914 · Cited by 86
RetractedAutophagic activity in neuronal cell death
Button, R. W., Luo, S., & Rubinsztein, D. C. (2015) · Neuroscience Bulletin · doi:10.1007/s12264-015-1528-y · Cited by 91
Self-citationIvankovic, D., Drew, J., Lesept, F., White, I. J., López Doménech, G., Tooze, S. A., & Kittler, J. T. (2020) · Autophagy · doi:10.1080/15548627.2019.1615302 · Cited by 85
Autophagy in Synucleinopathy: The Overwhelmed and Defective Machinery
Arotçarena, M.-L., Teil, M., & Dehay, B. (2019) · Cells · doi:10.3390/cells8060565 · Cited by 97
Molecular Insights into Parkinson's Disease
Rochet, J., Hay, B. A., & Guo, M. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385883-2.00011-4 · Cited by 96
Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases
Sonninen, T.-M., Goldsteins, G., Laham-Karam, N., Koıstınaho, J., & Lehtonen, Š. (2020) · Cells · doi:10.3390/cells9102183 · Cited by 99
Molecular machinery of macroautophagy and its deregulation in diseases
Wong, A. S. L., Cheung, Z. H., & Ip, N. Y. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.07.005 · Cited by 102
Sheng, Y., Song, Y., Li, Z., Wang, Y., Lin, H., Cheng, H., & Zhou, R. (2017) · Cell Death and Differentiation · doi:10.1038/s41418-017-0023-1 · Cited by 93
Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration
Peng, W., Minakaki, G., Nguyen, M., & Krainc, D. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00742-3 · Cited by 79
Role of Ubiquitin–Proteasome and Autophagy-Lysosome Pathways in α-Synuclein Aggregate Clearance
Sahoo, S., Padhy, A. A., Kumari, V., & Mishra, P. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02897-1 · Cited by 91
“Overexpression of wild-type α-synuclein in mammalian cells and transgenic mice effects Rab1a-specific secretory pathways, hampering omegasome (autophagosome precursor) formation as manifested by decreased localization of autophagy protein Atg9 with transGolgi network and its reduced levels in LC3 positive vesicles [96…”
BackgroundDoxycycline Inhibits α-Synuclein-Associated Pathologies in Vitro and in Vivo
Dominguez-Meijide, A., Parrales, V., Vasili, E., González-Lizárraga, F., König, A., Lázaro, D. F., Lannuzel, A., Haik, S., Del Bel, E., Chehín, R., et al. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105256 · Cited by 81
Petroi, D., Popova, B., Taheri-Talesh, N., Irniger, S., Shahpasandzadeh, H., Zweckstetter, M., Outeiro, T. F., & Braus, G. H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.361865 · Cited by 81
α-synuclein impairs autophagosome maturation through abnormal actin stabilization
Sarkar, S., Olsen, A. L., Sygnecka, K., Lohr, K. M., & Feany, M. Β. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009359 · Cited by 85
Lysosomal Stress Response (LSR): Physiological Importance and Pathological Relevance
Lakpa, K. L., Khan, N., Afghah, Z., Chen, X., & Geiger, J. D. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-09990-7 · Cited by 88
Wong, V. K. W., Wu, A., Wang, J., Liu, L., & Law, B. Y. K. (2015) · Molecules · doi:10.3390/molecules20033496 · Cited by 83
Harrington, A. J., Yacoubian, T. A., Slone, S. R., Caldwell, K. A., & Caldwell, G. A. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2606-11.2012 · Cited by 82
Wang, J.-D., Cao, Y.-L., Li, Q., Yang, Y., Jin, M., Chen, D., Wang, F., Wang, G., Qin, Z., Hu, L., et al. (2015) · Autophagy · doi:10.1080/15548627.2015.1100930 · Cited by 88
Molecular Events Underlying Parkinson’s Disease – An Interwoven Tapestry
Lim, K., & Zhang, C. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00033 · Cited by 93
Molecular pathogenesis of Parkinson's disease: update
Saiki, S., Sato, S., & Hattori, N. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301205 · Cited by 105
Targeting α-Synuclein for PD Therapeutics: A Pursuit on All Fronts
Teil, M., Arotçarena, M.-L., Faggiani, E., Laferrière, F., Bézard, E., & Dehay, B. (2020) · Biomolecules · doi:10.3390/biom10030391 · Cited by 85
Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson’s Disease
Cardinale, A., Calabrese, V., de Iure, A., & Picconi, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126517 · Cited by 90
Xie, Q., Yang, Y., Huang, J., Ninkovic, J., Walcher, T., Wolf, L., Vitenzon, A., Zheng, D., Götz, M., Beebe, D. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054507 · Cited by 78
The link between the SNCA gene and parkinsonism
Xu, W., Tan, L., & Yu, J. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.042 · Cited by 86
(Poly)phenols protect from α-synuclein toxicity by reducing oxidative stress and promoting autophagy
Macedo, D., Tavares, L., McDougall, G. J., Vicente Miranda, H., Stewart, D., Ferreira, R. B., Tenreiro, S., Outeiro, T. F., & Santos, C. N. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddu585 · Cited by 76
Common Mechanisms Underlying α-Synuclein-Induced Mitochondrial Dysfunction in Parkinson’s Disease
Sohrabi, T., Mirzaei-Behbahani, B., Zadali, R., Pirhaghi, M., Morozova‐Roche, L. A., & Meratan, A. A. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.167992 · Cited by 86
Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson’s Disease
Bobela, W., Aebischer, P., & Schneider, B. L. (2015) · Biomolecules · doi:10.3390/biom5042675 · Cited by 78
Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease
Pitcairn, C., Wani, W. Y., & Mazzulli, J. R. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.03.008 · Cited by 75
Autophagy—from molecular mechanisms to clinical relevance
Lippai, M., & Szatmári, Z. (2016) · Cell Biology and Toxicology · doi:10.1007/s10565-016-9374-5 · Cited by 83
Mechanisms of alpha-synuclein toxicity: An update and outlook
(2020) · Progress in Brain Research · doi:10.1016/bs.pbr.2019.10.005 · Cited by 75
Park, H. J., Shin, J. Y., Kim, H. N., Oh, S. H., & Lee, P. H. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.028 · Cited by 75
Wu, G., Wang, X., Feng, X., Zhang, A., Li, J., Gu, K., Huang, J. A., Pang, S., Dong, H., Gao, H., et al. (2011) · Brain Research · doi:10.1016/j.brainres.2011.04.013 · Cited by 81
Autophagy in Astrocytes and its Implications in Neurodegeneration
Sung, K., & Jiménez-Sánchez, M. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.12.041 · Cited by 80
Chu, Y., Goldman, J. G., Kelly, L. P., He, Y., Waliczek, T., & Kordower, J. H. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.003 · Cited by 74
Small GTPase Rab1B is associated with ATG9A vesicles and regulates autophagosome formation
Kakuta, S., Yamaguchi, J., Suzuki, C., Sasaki, M., Kazuno, S., & Uchiyama, Y. (2017) · The FASEB Journal · doi:10.1096/fj.201601052r · Cited by 74
“GFP-Rab1B is known to colocalize with LC3, and the inhibition of Rab1A and -B is known to decrease the number of LC3 dots (29, 30).”
BackgroundImpaired protein degradation in FTLD and related disorders
Götzl, J. K., Lang, C. M., Haass, C., & Capell, A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.008 · Cited by 79
“…of such pathologic protein aggregates reduces the efficiency of the two major protein degradation systems, UPS (Bence et al. 2001, Bennett et al. 2005, Emmanouilidou et al. 2010, Jana et al. 2001) and the autophagy-lysosome system (Cuervo et al. 2004, Wang et al. 2009, Winslow et al. 2010).”
BackgroundTriplett, J. C., Tramutola, A., Swomley, A. M., Kirk, J. M., Grimes, K. M., Hardell, K. N. L., Orr, M. E., Rodriguez, K. A., Cai, J., Klein, J. B., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.08.002 · Cited by 82
Wang, T., & Hay, J. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00433 · Cited by 81
“…groups have demonstrated potent inhibition of ER-to-Golgi transport by physiologically relevant over-expression levels of a-syn in normal rat kidney cells, HeLa cells, neuroendocrine PC12 cells, and dopaminergic SH-SY5Y cells (Thayanidhi et al., 2010; Winslow et al., 2010; Oaks et al., 2013).”
BackgroundZhang, S., Eitan, E., Wu, T.-Y., & Mattson, M. P. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.09.016 · Cited by 73
“…aggregates and neurological deficits similar to PD (Hara et al., 2006; Komatsu et al., 2006), while overexpression of wild type α-synuclein or its mutants inhibits autophagy (Chen et al., 2015; Chew et al., 2011; Choubey et al., 2011; Huang et al., 2012; Koch et al., 2015; Winslow et al., 2010).”
BackgroundWu, J.-Z., Ardah, M. T., Haikal, C., Svanbergsson, A., Diepenbroek, M., Vaikath, N. N., Li, W., Wang, Z., Outeiro, T. F., El‐Agnaf, O. M. A., et al. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0159-7 · Cited by 78
Defective Autophagy in Parkinson’s Disease: Lessons from Genetics
Zhang, H., Duan, C., & Yang, H. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8787-5 · Cited by 79
The relationship of alpha-synuclein to mitochondrial dynamics and quality control
Thorne, N. J., & Tumbarello, D. A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.947191 · Cited by 82
“Previous research has implicated a protective role for the small GTPase Rab1 against alpha-synuclein toxicity in the context of ER-Golgi vesicular trafficking and autophagy (Cooper et al., 2006; Winslow et al., 2010).”
InfluentialYpt1/Rab1 regulates Hrr25/CK1δ kinase activity in ER–Golgi traffic and macroautophagy
Wang, J., Davis, S., Menon, S., Zhang, J., Ding, J., Cervantes, S., Miller, E. A., Jiang, Y., & Ferro‐Novick, S. (2015) · The Journal of Cell Biology · doi:10.1083/jcb.201408075 · Cited by 79
“Ypt1 and its mammalian homologue Rab1 were previously reported to be required for macroautophagy (Lynch-Day et al., 2010; Winslow et al., 2010).”
BackgroundRegulation of autophagy by polyphenols: Paving the road for treatment of neurodegeneration
Nabavi, S. F., Sureda, A., Dehpour, A. R., Shirooie, S., Sanches-Silva, A. T., Devi, K. P., Ahmed, T., Ishaq, N., Hashim, R., Sobarzo‐Sánchez, E., et al. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.12.001 · Cited by 77
Regulation of neuronal autophagy and the implications in neurodegenerative diseases
Cai, Q., & Ganesan, D. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105582 · Cited by 75
Glucocerebrosidase-associated Parkinson disease: Pathogenic mechanisms and potential drug treatments
Gegg, M. E., Menozzi, E., & Schapira, A. H. V. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105663 · Cited by 83
Anandhan, A., Rodriguez-Rocha, H., Bohovych, I., Griggs, A. M., Zavala-Flores, L., Reyes-Reyes, E. M., Seravalli, J., Stanciu, L. A., Lee, J., Rochet, J.-C., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.11.018 · Cited by 71
“C). αsynuclein is known to interfere with autophagic pathways (Martinez-Vicente et al., 2008; Winslow et al., 2010).”
ALS-associated mutant FUS inhibits macroautophagy which is restored by overexpression of Rab1
Soo, K. Y., Sultana, J. M., King, A. E., Atkinson, R., Warraich, S. T., Sundaramoorthy, V., Blair, I. P., Farg, M. A., & Atkin, J. D. (2015) · Cell Death Discovery · doi:10.1038/cddiscovery.2015.30 · Cited by 78
Autophagy Modulation as a Treatment of Amyloid Diseases
Mputhia, Z., Hone, E., Tripathi, T., Sargeant, T. J., Martins, R. N., & Bharadwaj, P. (2019) · Molecules · doi:10.3390/molecules24183372 · Cited by 70
The multi‐faceted role of mitochondria in the pathology of Parkinson’s disease
Trinh, D., Israwi, A. R., Arathoon, L. R., Gleave, J. A., & Nash, J. E. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15154 · Cited by 74
“…of α-synuclein also impairs macroautophagy, and aggregated α-synuclein impairs the UPS, indicating that mutant α-synuclein overwhelms degradation processes responsible for the removal of damaged proteins and cellular content (Snyder et al., 2003; Winslow et al., 2010; Zhang, Zhang, et al., 2008)2.”
BackgroundAlpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease
Saramowicz, K., Siwecka, N., Galita, G., Kucharska-Lusina, A., Rozpędek‐Kamińska, W., & Majsterek, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010360 · Cited by 87
“…WT α Syn was shown to inhibit both ALP pathways, mainly via mislocalization of autophagy-related protein 9 (ATG9) and a decrease in GCase activity [192,193]. α Syn was also shown to alter MA by inhibiting the Rab1 pathway and high mobility group box 1 (HMGB1)- Beclin1 complex formation, which are…”
Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targets
Qian, S., Long, Y., Tan, G., Li, X., Xiang, B., Tao, Y., Xie, Z., & Zhang, X. (2024) · MedComm · doi:10.1002/mco2.70024 · Cited by 94
Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinsons Disease
Rivero-Ríos, P., Madero-Pérez, Fernández, B., & Hilfiker, S. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666151030103027 · Cited by 69
Autophagic flux control in neurodegeneration: Progress and precision targeting—Where do we stand?
Lumkwana, D., du Toit, A., Kinnear, C. J., & Loos, B. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.03.006 · Cited by 75
“In Parkinson’s disease, overexpression of a-synuclein has been shown to inhibit autophagy in mammalian cells, drosophila and mice (Winslow et al., 2010) by misplacing ATG9, a transmembrane protein that is essential for the expansion of the phagophore (Klionsky et al.”
Autophagy and ageing: Insights from invertebrate model organisms
Lionaki, E., Markaki, M., & Tavernarakis, N. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.05.001 · Cited by 61
“Overexpression of Rab1a restores autophagy defect caused by -synuclein in the fly brain (Winslow et al., 2010).”
BackgroundMechanism and Regulation of Autophagy and Its Role in Neuronal Diseases
Hu, Z., Yang, B., Mo, X., & Xiao, H. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8921-4 · Cited by 73
Lonskaya, I., Hebron, M. L., Algarzae, N. K., Desforges, N., & Moussa, C. E.-H. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.12.018 · Cited by 68
“Additionally, a-Synuclein aggregates were previously shown to alter parkin solubility in sporadic PD (Kawahara et al., 2008) and inhibit macro-autophagy in cell models and transgenic animals (Winslow et al., 2010).”
The Role of Glia in Alpha-Synucleinopathies
Fellner, L., & Stefanova, N. (2013) · Molecular Neurobiology · doi:10.1007/s12035-012-8340-3 · Cited by 68
Bifunctional Anti-Non-Amyloid Component α-Synuclein Nanobodies Are Protective In Situ
Butler, D. C., Joshi, S. N., Genst, E. D., Baghel, A. S., Dobson, C. M., & Messer, A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0165964 · Cited by 68
Keeling, E., Lotery, A. J., Tumbarello, D. A., & Ratnayaka, J. A. (2018) · Cells · doi:10.3390/cells7020016 · Cited by 81
Krishnan, P. D. G., Golden, E., Woodward, E., Pavlos, N. J., & Blancafort, P. (2020) · Cancers · doi:10.3390/cancers12020259 · Cited by 84
Kumar, A., Ganini, D., & Mason, R. P. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0135-y · Cited by 67
“As shown by several investigators, these oligomers can further impair several important rescue processes like autophagy [52, 53] and make cells more prone to accumulate damage.”
Consequences of Rab GTPase dysfunction in genetic or acquired human diseases
Banworth, M. J., & Li, G. (2017) · Small GTPases · doi:10.1080/21541248.2017.1397833 · Cited by 77
Lei, Z., Cao, G., & Wei, G. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1364-0 · Cited by 75
Intermediate compartment (IC): from pre-Golgi vacuoles to a semi-autonomous membrane system
Saraste, J., & Marie, M. (2018) · Histochemistry and Cell Biology · doi:10.1007/s00418-018-1717-2 · Cited by 66
Wang, X., Feng, S., Wang, Y., Yuan, Y., Li, Z., Chen, N., Wang, Z., & Zhang, Y. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01039-w · Cited by 67
Kovács, Z., Brunner, B., & Ari, C. (2021) · Nutrients · doi:10.3390/nu13072197 · Cited by 76
The Emerging Roles of Autophagy in Human Diseases
Lei, Y., & Klionsky, D. J. (2021) · Biomedicines · doi:10.3390/biomedicines9111651 · Cited by 70
“For instance, some core ATG genes were identified in the screen, including ATG4B, ATG2B, ATG5 and ATG9A, and the mutation in ATG4B decreases its interaction with LC3.”
BackgroundInfluentialProteomic analysis of endocytic vesicles: Rab1a regulates motility of early endocytic vesicles
Mukhopadhyay, A., Nieves, E., Che, F.-Y., Wang, J., Jin, L., Murray, J. W., Gordon, K., Angeletti, R. H., & Wolkoff, A. W. (2011) · Journal of Cell Science · doi:10.1242/jcs.079020 · Cited by 66
“Transient transfections into HeLa and HEK293 cells resulted in complete fragmentation of the Golgi in some reports (Hyvola et al., 2006; Razi et al., 2009; Winslow et al., 2010), whereas less or no fragmentation in others (Dejgaard et al., 2008; DumaresqDoiron et al., 2010).”
BackgroundLittle, D., Luft, C., Mosaku, O., Lorvellec, M., Yao, Z., Paillusson, S., Kriston-Vizi, J., Gandhi, S., Abramov, A. Y., Ketteler, R., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-27058-0 · Cited by 66
Intracellular and Intercellular Mitochondrial Dynamics in Parkinson’s Disease
Valdinocci, D., Simões, R. F., Kovářová, J., Cunha‐Oliveira, T., Neužil, J., & Pountney, D. L. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00930 · Cited by 73
“Evidence for a role of mitophagy in PD includes the observation that α-syn overexpression decreases the level of LC3positive vesicles in human neuroblastoma cells (Winslow et al., 2010).”
BackgroundOttolini, D., Calí, T., Szabó, I., & Brini, M. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0201 · Cited by 73
Zhu, J., Gao, W., Shan, X., Wang, C., Wang, H., Shao, Z., Dou, S., Jiang, Y., Wang, C., & Cheng, B. (2020) · Brain Research · doi:10.1016/j.brainres.2019.146493 · Cited by 65
Khan, M. R., Yin, X., Kang, S.-U., Mitra, J., Wang, H., Ryu, T., Brahmachari, S., Karuppagounder, S. S., Kimura, Y., Jhaldiyal, A., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.add0499 · Cited by 64
“1D) consistent with the role of endolysosomal pathways and disruption of macroautophagy and chaperone-mediated autophagy in the pathogenesis of pathologic α-synuclein ( 11 , 12 ).”
BackgroundTherapeutic induction of autophagy to modulate neurodegenerative disease progression
Hochfeld, W. E., Lee, S., & Rubinsztein, D. C. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.189 · Cited by 64
Self-citationFan, R. Z., Guo, M., Luo, S., Cui, M., & Tieu, K. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0821-4 · Cited by 64
Kannangara, A. R., Poole, D. M., McEwan, C. M., Youngs, J. C., Weerasekara, V. K., Thornock, A. M., Lazaro, M. T., Balasooriya, E. R., Oh, L. M., Soderblom, E. J., et al. (2021) · EMBO reports · doi:10.15252/embr.202051136 · Cited by 64
“Furthermore, defective ATG9A trafficking (or genetic loss of ATG9A) is associated with impaired clearance of protein aggregates (Winslow et al , 2010; De Pace et al , 2018; Yamaguchi et al , 2018).”
Serratos, I. N., Hernández‐Pérez, E., Campos, C., Aschner, M., & Santamaría, A. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02596-3 · Cited by 75
Coune, P., Bensadoun, J., Aebischer, P., & Schneider, B. L. (2011) · Journal of Parkinson s Disease · doi:10.3233/jpd-2011-11058 · Cited by 66
Li, L., Nadanaciva, S., Berger, Z., Shen, W., Paumier, K., Schwartz, J., Mou, K., Loos, P., Milici, A. J., Dunlop, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0085815 · Cited by 63
Overexpression of α‐synuclein in an astrocyte cell line promotes autophagy inhibition and apoptosis
Erustes, A. G., Stefani, F. Y., Terashima, J. Y., Stilhano, R. S., Monteforte, P. T., da Silva Pereira, G. J., Han, S. W., Calgarotto, A. K., Hsu, Y., Ureshino, R. P., et al. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24092 · Cited by 64
“Consistent with our findings, Winslow et al. (2010) have demonstrated that a-synuclein overexpression was associated with a decrease in autophagic flux, where the LC3-II/LC3-I ratio was reduced and p62 protein levels were increased, in cell cultures and animal models.”
ResultBaksi, S., & Singh, N. (2017) · Scientific Reports · doi:10.1038/s41598-017-12862-x · Cited by 66
C9orf72 plays a central role in Rab GTPase-dependent regulation of autophagy
Webster, C. P., Smith, E. F., Grierson, A. J., & Vos, K. J. D. (2016) · Small GTPases · doi:10.1080/21541248.2016.1240495 · Cited by 74
Trifluoperazine rescues human dopaminergic cells from wild-type α-synuclein-induced toxicity
Höllerhage, M., Goebel, J. N., de Andrade, A., Hildebrandt, T., Dolga, A. M., Culmsee, C., Oertel, W. H., Hengerer, B., & Höglinger, G. U. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.027 · Cited by 66
Dunning, C. J. R., George, S., & Brundin, P. (2013) · Prion · doi:10.4161/pri.23806 · Cited by 63
Manzoni, C., & Lewis, P. A. (2013) · The FASEB Journal · doi:10.1096/fj.12-223842 · Cited by 63
The emerging role of Rab GTPases in the pathogenesis of Parkinson's disease
Gao, Y., Wilson, G. R. A., Stephenson, S. E. M., Bozaoglu, K., Farrer, M. J., & Lockhart, P. J. (2018) · Movement Disorders · doi:10.1002/mds.27270 · Cited by 70
“Furthermore, the authors demonstrated that increased dosage of aSN impairs autophagy by inhibiting RAB1A activity, culminating in the mislocalization of Autophagy-related protein 9 (ATG9), a protein that regulates the formation of autophagosome precursors.(70) In another study, the overexpression of human WT aSN in a…”
BackgroundMallucci, G. R., Klenerman, D., & Rubinsztein, D. C. (2020) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-040320-120625 · Cited by 62
Self-citationKim, S., Kim, D. K., Jeong, S., & Lee, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115894 · Cited by 75
Herman, S., Djaldetti, R., Mollenhauer, B., & Offen, D. (2023) · Brain · doi:10.1093/brain/awac261 · Cited by 62
Su, C., Feng, Y. Y., Liu, T., Liu, X., Bao, J., Shi, A., Hu, D., Liu, T., & Yu, Y. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12721 · Cited by 63
Role of alpha-synuclein in autophagy modulation of primary human T lymphocytes
Colasanti, T., Vomero, M., Alessandri, C., Barbati, C., Maselli, A., Camperio, C., Conti, F., Tinari, A., Carlo-Stella, C., Tuosto, L., et al. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.211 · Cited by 61
“Consistently with our results, Winslow et al.10 demonstrated that a-synuclein overexpression impairs autophagy.”
Result
Metadata
- Authors
- Winslow, A. R., Chen, C.-W., Corrochano, S., Acevedo-Arozena, A., Gordon, D. E., Peden, A. A., Lichtenberg, M., Menzies, F. M., Ravikumar, B., Imarisio, S., Brown, S., O’Kane, C. J., & Rubinsztein, D. C.
- Affiliations
- University of Cambridge (GB)
- Medical Research Council (GB)
- Mammalian Genetics Unit, Medical Research Council Harwell, Oxfordshire OX11 0RD, England, UK 4
- Corresponding author
- Rubinsztein, David C.
- ORCID
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2010-09-20
- Volume
- 190
- Issue
- 6
- Pages
- 1023-1037
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC3101586
- OpenAlex
- W2142047537
- Cited by
- 825
- References
- 51
- Citations by year
- 2026: 36 · 2025: 41 · 2024: 55 · 2023: 45 · 2022: 42 · 2021: 51 · 2020: 66 · 2019: 72 · 2018: 57 · 2017: 66 · 2016: 65 · 2015: 53 · 2014: 37 · 2013: 43 · 2012: 51
- FWCI
- 26.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Cell Biology (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Funders
- Wellcome Trust (FP7/2007–2013, 089703)
- European Commission (241791)
- Cambridge Trust
- Medical Research Council (MC_G1000734)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- alpha-synuclein, macroautophagy, Parkinson's disease, Rab1A, Atg9, Lewy bodies, transgenic mice
- MeSH terms
- Animals, Autophagy, Drosophila melanogaster, Golgi Apparatus, Humans, Membrane Proteins, Microtubule-Associated Proteins, Models, Biological, Parkinson Disease, Phagosomes, rab1 GTP-Binding Proteins, Protein Transport, Secretory Vesicles, Cell Line, Tumor, Mice, alpha-Synuclein, Gene Knockdown Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.